Here we draw on evidence on the mechanism of DNA transactions in Escherichia coli, yeast, Drosophila, mammals, and human cancer to derive a model for the origin of CNV based on the mechanism of BIR occurring at sites of microhomology (microhomology-mediated BIR or MMBIR). Here, KCNJ11 is linked to cancer.